Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals alpha-globin triplication prevalence and its impact on haemoglobin levels in patients with beta-globin mutations.
We aimed to ascertain the prevalence of αααanti-3.7 and αααanti-4.2 triplications in central Thailand and to characterise the phenotypes of individuals harbouring these variants. We performed a retrospective review of adult (≥ 18 years) samples submitted for polymerase chain reaction-based α-globin mutation analysis at Siriraj Hospital, Mahidol University, Bangkok (January 2012-December 2021). Haematological indices were compared between carriers and non-carriers of α-globin triplications, and clinical severity was assessed in those with co-inherited β-globin mutations. Among 1559 subjects, α-globin triplication prevalence was 1.28%, with αααanti-4.2 (0.83%) more frequent than αααanti-3.7 (0.45%). Double heterozygosity for an α triplication and a β-globin mutation occurred in 0.9%. Individuals carrying αααanti-3.7 or αααanti-4.2 had lower mean haemoglobin levels (10.00 and 11.23 ± 1.85 g/dL, respectively) than those without triplication (12.35 ± 2.59 g/dL). Among heterozygous β-thalassaemia individuals, co-inheritance of αααanti-3.7 or αααanti-4.2 was associated with significantly reduced mean haemoglobin (8.38 ± 1.58 and 8.28 ± 1.15 g/dL, respectively). This contrasts with the non-triplication group (11.14 ± 1.86 g/dL). Of 14 subjects with double heterozygosity, 8 had thalassaemia intermedia and 6 had thalassaemia trait. Although uncommon in central Thailand, α-globin triplications can exacerbate anaemia in individuals with co-inherited heterozygous β-globin mutations, supporting routine screening in symptomatic cases. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
No takes yet. Share an insight, caveat, or question.
Chutvanichkul et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: